Perspectives on Clinical Biomarkers Based on the Pathophysiology of Arrhythmias
1Department of Cardiovascular Medicine Tokushima University Graduate School of Biomedical Sciences Tokushima Japan.
Insights
Biomarkers from blood tests aid in understanding paroxysmal arrhythmias like atrial fibrillation, helping predict onset and complications, though electrocardiograms (ECGs) remain key for diagnosis.
Area of Science:
- Cardiology
- Biochemistry
Background:
- Arrhythmias require electrocardiograms (ECGs) for diagnosis, especially paroxysmal types.
- Biomarkers are not primary diagnostic tools but offer insights into arrhythmia prevalence and risk.
Purpose of the Study:
- To define biomarkers in the context of arrhythmias.
- To discuss the role of biomarkers, particularly in relation to atrial fibrillation and its complications.
Main Methods:
- Literature review and definition of biomarkers.
- Analysis of existing studies on biomarker utility in arrhythmias.
Main Results:
- Biomarkers are substances measurable via blood tests.
- Research predominantly focuses on biomarkers for atrial fibrillation, but also explores ventricular arrhythmias and sudden death prediction.
Conclusions:
- Biomarkers are valuable for assessing paroxysmal arrhythmia prevalence, onset prediction, severity, and complication risk.
- While ECGs are essential for diagnosis, biomarkers provide complementary prognostic information, especially for atrial fibrillation.
Abstract:
Arrhythmias are diagnosed using electrocardiograms (ECGs). Particularly for paroxysmal arrhythmias, an ECG recorded during an episode is essential for definitive diagnosis. Meanwhile, biomarkers assessable through blood tests do not directly diagnose arrhythmias, but are considered useful for evaluating the prevalence of paroxysmal arrhythmias, predicting their onset, assessing severity, and evaluating the risk of complications. While most biomarker research in the arrhythmia field focuses on atrial fibrillation, several studies have also reported on the prediction of ventricular arrhythmias and sudden death. This paper defines biomarkers as substances measurable and evaluable through blood tests and primarily discusses their relationship with atrial fibrillation and its complications.
Related Concept Videos
01:28Mechanism of Cardiac Arrhythmias
01:30Dysrhythmias V: Evaluating Dysrhythmias
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...